Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Impact of IVIG therapy on serologic testing for infectious diseases.

Hanson KE, Gabriel N, Mchardy I, Hoffmann W, Cohen SH, Couturier MR, Thompson GR 3rd.

Diagn Microbiol Infect Dis. 2020 Feb;96(2):114952. doi: 10.1016/j.diagmicrobio.2019.114952. Epub 2019 Nov 23.

PMID:
31787407
2.

Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis.

Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, Bender J, Dien Bard J, Murkey J, Carlson M, Vespa PM, Vijayan T, Allyn PR, Campeau S, Humphries RM, Klausner JD, Ganzon CD, Memar F, Ocampo NA, Zimmermann LL, Cohen SH, Polage CR, DeBiasi RL, Haller B, Dallas R, Maron G, Hayden R, Messacar K, Dominguez SR, Miller S, Chiu CY.

N Engl J Med. 2019 Jun 13;380(24):2327-2340. doi: 10.1056/NEJMoa1803396.

3.

Isavuconazole in the Treatment of Coccidioidal Meningitis.

Heidari A, Quinlan M, Benjamin DJ, Laurence B, Mu A, Ngai T, Hoffman WJ, Cohen SH, McHardy I, Johnson R, Thompson GR 3rd.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02232-18. doi: 10.1128/AAC.02232-18. Print 2019 Mar.

4.

The uroplakin plaque promotes renal structural integrity during congenital and acquired urinary tract obstruction.

Jackson AR, Li B, Cohen SH, Ching CB, McHugh KM, Becknell B.

Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1019-F1031. doi: 10.1152/ajprenal.00173.2018. Epub 2018 Jun 13.

5.

Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis.

Stewart ER, Eldridge ML, McHardy I, Cohen SH, Thompson GR 3rd.

Mycopathologia. 2018 Jun;183(3):619-622. doi: 10.1007/s11046-017-0240-7. Epub 2018 Jan 16.

PMID:
29340909
6.

Antimicrobial stewardship programs that target only high-cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infections.

Bui C, Zhu E, Donnelley MA, Wilson MD, Morita M, Cohen SH, Brown J.

Am J Infect Control. 2016 Dec 1;44(12):1684-1686. doi: 10.1016/j.ajic.2016.06.025.

PMID:
27908435
7.

Toxin Immunoassays and Clostridium difficile Infection-Reply.

Polage CR, Solnick JV, Cohen SH.

JAMA Intern Med. 2016 Mar;176(3):414-5. doi: 10.1001/jamainternmed.2015.8539. No abstract available.

PMID:
26954051
8.

The never-ending struggle with laboratory testing for Clostridium difficile infection.

Polage CR, Turkiewicz JV, Cohen SH.

J Comp Eff Res. 2016 Mar;5(2):113-6. doi: 10.2217/cer-2016-0001. Epub 2016 Mar 1. No abstract available.

9.

State-of-the-Art Microbiologic Testing for Community-Acquired Meningitis and Encephalitis.

Polage CR, Cohen SH.

J Clin Microbiol. 2016 May;54(5):1197-202. doi: 10.1128/JCM.00289-16. Epub 2016 Feb 17. Review.

10.

Curbing antimicrobial resistance: Do physicians receive adequate education about antibiograms?

Nand P, Wilson MD, Cohen SH, Brown J.

J Infect. 2016 Jan;72(1):127-9. doi: 10.1016/j.jinf.2015.09.036. Epub 2015 Oct 9. No abstract available.

11.

Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Polage CR, Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, Nguyen HH, Huang B, Tang YW, Lee LW, Kim K, Taylor S, Romano PS, Panacek EA, Goodell PB, Solnick JV, Cohen SH.

JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.

12.

In vitro interactions between amphotericin B and hydrocortisone: potential implications for intrathecal therapy.

Hodge G, Cohen SH, Thompson GR 3rd.

Med Mycol. 2015 Sep;53(7):749-53. doi: 10.1093/mmy/myv047. Epub 2015 Jul 10.

PMID:
26162473
13.

Swabbing Surgical Sites Does Not Improve the Detection of Staphylococcus aureus Carriage in High-Risk Surgical Patients.

Brown J, Li CS, Giordani M, Shahlaie K, Klineberg EO, Tripet-Diel JR, Ihara MS, Cohen SH.

Surg Infect (Larchmt). 2015 Oct;16(5):523-5. doi: 10.1089/sur.2014.232. Epub 2015 Jun 26.

14.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, Van Schooneveld TC, Pardi DS, Ramos A, Barron MA, Chen H, Villano S.

JAMA. 2015 May 5;313(17):1719-27. doi: 10.1001/jama.2015.3725.

PMID:
25942722
15.

Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion.

Gupta MP, Coombs P, Prockop SE, Hasan AA, Doubrovina E, O'Reilly RJ, Cohen SH, Park SS, Kiss S.

Ophthalmic Surg Lasers Imaging Retina. 2015 Jan;46(1):80-2. doi: 10.3928/23258160-20150101-14.

16.

Cutaneous manifestations of infection in returning travelers.

Eldridge M, Cohen SH.

Curr Infect Dis Rep. 2014 Oct;16(10):426. doi: 10.1007/s11908-014-0426-9.

PMID:
25129114
17.

A pain in the neck: thyroid abscess.

Brown J, Nguyen HH, Cohen SH.

Am J Med. 2014 Mar;127(3):e5-6. doi: 10.1016/j.amjmed.2013.09.036. Epub 2013 Oct 29. No abstract available.

PMID:
24365163
18.

The road ahead: practice integration in gastroenterology.

Cohen LB, Beckman MS, Cohen SH.

Clin Gastroenterol Hepatol. 2013 Jun;11(6):589-92. doi: 10.1016/j.cgh.2013.03.008. No abstract available.

PMID:
23684179
19.

Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis.

Goldenholz DM, Mehra N, Dahlin B, Cohen SH, Wheelock VL.

Neurology. 2013 Feb 19;80(8):e82. doi: 10.1212/WNL.0b013e3182825041. No abstract available.

PMID:
23420900
20.

Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid.

Thompson GR 3rd, Sharma S, Bays DJ, Pruitt R, Engelthaler DM, Bowers J, Driebe EM, Davis M, Libke R, Cohen SH, Pappagianis D.

Chest. 2013 Mar;143(3):776-781. doi: 10.1378/chest.12-1312.

21.

Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests.

Gyorke CE, Wang S, Leslie JL, Cohen SH, Solnick JV, Polage CR.

J Clin Microbiol. 2013 Jan;51(1):278-80. doi: 10.1128/JCM.02120-12. Epub 2012 Oct 10.

22.

Outcomes in patients tested for Clostridium difficile toxins.

Polage CR, Chin DL, Leslie JL, Tang J, Cohen SH, Solnick JV.

Diagn Microbiol Infect Dis. 2012 Dec;74(4):369-73. doi: 10.1016/j.diagmicrobio.2012.08.019. Epub 2012 Sep 23.

23.

Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?

Leslie JL, Cohen SH, Solnick JV, Polage CR.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3295-9. doi: 10.1007/s10096-012-1695-6. Epub 2012 Jul 20. Erratum in: Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3301.

24.

Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile.

Polage CR, Solnick JV, Cohen SH.

Clin Infect Dis. 2012 Oct;55(7):982-9. doi: 10.1093/cid/cis551. Epub 2012 Jun 14. Review.

25.

Serum (1->3)-β-D-glucan measurement in coccidioidomycosis.

Thompson GR 3rd, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA.

J Clin Microbiol. 2012 Sep;50(9):3060-2. doi: 10.1128/JCM.00631-12. Epub 2012 Jun 12.

26.

Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection.

Thompson GR 3rd, Bays D, Taylor SL, Cohen SH, Pappagianis D.

Med Mycol. 2013 Apr;51(3):319-23. doi: 10.3109/13693786.2012.690536. Epub 2012 Jun 11.

27.

Hepatic mucormycosis with abscess formation.

Su H, Thompson GR 3rd, Cohen SH.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):192-4. doi: 10.1016/j.diagmicrobio.2012.02.021. Epub 2012 Apr 12.

PMID:
22502961
28.

Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Browne SK, Zaman R, Sampaio EP, Jutivorakool K, Rosen LB, Ding L, Pancholi MJ, Yang LM, Priel DL, Uzel G, Freeman AF, Hayes CE, Baxter R, Cohen SH, Holland SM.

Blood. 2012 Apr 26;119(17):3933-9. doi: 10.1182/blood-2011-12-395707. Epub 2012 Mar 8.

29.

Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.

Thompson GR 3rd, Bays D, Cohen SH, Pappagianis D.

Antimicrob Agents Chemother. 2012 Jan;56(1):563-4. doi: 10.1128/AAC.05275-11. Epub 2011 Oct 17.

30.

Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis.

Thompson GR 3rd, Lunetta JM, Johnson SM, Taylor S, Bays D, Cohen SH, Pappagianis D.

Clin Infect Dis. 2011 Sep;53(6):e20-4. doi: 10.1093/cid/cir466.

PMID:
21865185
31.

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America.

Infect Control Hosp Epidemiol. 2010 May;31(5):431-55. doi: 10.1086/651706.

PMID:
20307191
32.

Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis.

Rakoczy KS, Cohen SH, Nguyen HH.

Infect Control Hosp Epidemiol. 2008 Oct;29(10):927-32. doi: 10.1086/590667.

PMID:
18785863
33.

The continuing saga of MRSA.

Flynn N, Cohen SH.

J Infect Dis. 2008 May 1;197(9):1217-9. doi: 10.1086/533503. No abstract available.

PMID:
18422431
34.

Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection.

Huang H, Cohen SH, King JH, Monchaud C, Nguyen H, Flynn NM.

Diagn Microbiol Infect Dis. 2008 Apr;60(4):347-50. doi: 10.1016/j.diagmicrobio.2007.11.001. Epub 2008 Feb 21.

PMID:
18178362
35.
36.
37.

Epidemiologic surveillance of Clostridium difficile diarrhea in a freestanding pediatric hospital and a pediatric hospital at a university medical center.

Rexach CE, Tang-Feldman YJ, Cantrell MC, Cohen SH.

Diagn Microbiol Infect Dis. 2006 Oct;56(2):109-14. Epub 2006 May 4.

PMID:
16678379
38.

Prevalence of enterotoxigenic Bacteroides fragilis in hospital-acquired diarrhea.

Cohen SH, Shetab R, Tang-Feldman YJ, Sarma P, Silva J Jr, Prindiville TP.

Diagn Microbiol Infect Dis. 2006 Aug;55(4):251-4. Epub 2006 May 2.

PMID:
16650957
39.

Mode of action in relevance of rodent liver tumors to human cancer risk.

Holsapple MP, Pitot HC, Cohen SM, Boobis AR, Klaunig JE, Pastoor T, Dellarco VL, Dragan YP.

Toxicol Sci. 2006 Jan;89(1):51-6. Epub 2005 Oct 12. Erratum in: Toxicol Sci. 2006 Apr;90(2):596. Cohen, Samuel H [corrected to Cohen, Samuel M].

PMID:
16221960
40.

Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California.

Rexach CE, Tang-Feldman YJ, Cohen SH.

Infect Control Hosp Epidemiol. 2005 Aug;26(8):691-6.

PMID:
16156325
41.

Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital.

Martirosian G, Szczesny A, Cohen SH, Silva J Jr.

Diagn Microbiol Infect Dis. 2005 Jun;52(2):153-5.

PMID:
15964504
42.

Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998.

Tang-Feldman YJ, Henderson JP, Ackermann G, Feldman SS, Bedley M, Silva J Jr, Cohen SH.

Clin Infect Dis. 2005 May 15;40(10):1537-40. Epub 2005 Apr 12.

PMID:
15844079
43.
44.

Treatments for hepatitis B.

Asmuth DM, Nguyen HH, Melcher GP, Cohen SH, Pollard RB.

Clin Infect Dis. 2004 Nov 1;39(9):1353-62. Epub 2004 Oct 12. Review.

PMID:
15494913
45.

Cloning and expression of Clostridium difficile toxin A gene (tcdA) by PCR amplification and use of an expression vector.

Ackermann G, Löffler B, Tang-Feldman YJ, Cohen SH, Silva J Jr, Rodloff AC.

Mol Cell Probes. 2004 Aug;18(4):271-4.

PMID:
15271388
46.

Amphotericin B: time for a new "gold standard".

Ostrosky-Zeichner L, Marr KA, Rex JH, Cohen SH.

Clin Infect Dis. 2003 Aug 1;37(3):415-25. Epub 2003 Jul 22.

PMID:
12884167
47.

Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile.

Ackermann G, Tang-Feldman YJ, Schaumann R, Henderson JP, Rodloff AC, Silva J, Cohen SH.

Clin Microbiol Infect. 2003 Jun;9(6):526-30.

48.
49.

Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.

Ackermann G, Degner A, Cohen SH, Silva J Jr, Rodloff AC.

J Antimicrob Chemother. 2003 Mar;51(3):599-603.

PMID:
12615860
50.

One-step cloning and expression of Clostridium difficile toxin B gene (tcdB).

Tang-Feldman YJ, Ackermann G, Henderson JP, Silva J Jr, Cohen SH.

Mol Cell Probes. 2002 Jun;16(3):179-83.

PMID:
12144768

Supplemental Content

Loading ...
Support Center